Moderna Wants All Adults To Get Its Booster Shot
Moderna wants all adults to get a booster with its covid vaccine. It made a formal request to the FDA, and approval may even come this week.
The independent source for health policy research, polling, and news.
12,541 - 12,560 of 112,219 Results
Moderna wants all adults to get a booster with its covid vaccine. It made a formal request to the FDA, and approval may even come this week.
Today's early morning highlights from the major news organizations.
Opinion writers take on these covid issues.
Editorial pages weigh in on these public health issues.
Read recent commentaries about drug-cost issues.
Bloomberg reports that although Mexico is "behind regional peers," it's now going to give shots to teens ages 15 to 17, and some minors will even get shots in the U.S. A global push for school meals, covid peaks and restrictions in Europe, and more are also in the news.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
Automated text messages to check up on how adult covid outpatients were doing lowered the death rate by 68% compared to controls. Separately, the Infectious Diseases Society of America has provided study-based advice for PPE use by health workers.
The state's attorney general began an investigation into e-cigarette maker Puff Bar and also sued Juul Labs founders over allegations they personally were involved in marketing products to younger users. Ivermectin is also in the news again. And the District of Columbia will drop its mask requirement.
The first human trial will begin in Brigham and Women's Hospital. Also, a study says morning cups of tea and coffee could be linked with lower risk of dementia.
News outlets cover the water problems in Mississippi's state capital. A worrisome smallpox sample mistake, falling U.S. premature birth numbers, an E coli outbreak and more are also reported.
The Institute for Clinical and Economic Review found price hikes on widely used medicines during 2020 that had no new clinical evidence to justify increases. The unsubstantiated increases cost $1.67 billion in 2020. Meanwhile, Viatris' insulin biosimilar will be priced at almost the same price as established sellers.
While patients in Texas feel the immediate fallout from that state's new restrictions, California begins making plans for the influx of women from other states seeking abortions. And U.S. Catholic bishops debate giving communion to politicians who support abortion rights.
Twelve states have filed a new lawsuit in federal court challenging President Biden's push to enforce vaccine mandates. The latest suit uses language from the 5th U.S. Circuit Court of Appeals blocking the administration's vaccine mandate. Additional news from Florida, Idaho, New York and Texas on resistance to mandates.
Two looks at the influence politician-doctors have in Congress, including on the surprise medical bill legislation. In other news, drinking water infrastructure, ivermectin, Fauci facing threats and more.
Pfizer wants the Food and Drug Administration to authorize use of its antiviral pill to treat covid. Meanwhile the federal government plans to buy 10 million courses of the pill at a price of $5 billion.
The FDA is expected to announce that all adults 18 and older can get the Pfizer covid booster, as concerns of a winter surge mount. And the Biden administration plans to spend billions to expand vaccine production with an eye toward sending more vaccines to poor countries.
Right before massive holiday travel, covid infections are again on the rise in many states. But Dr. Anthony Fauci said that families who are fully vaccinated against COVID-19 should "feel good" about gathering for the holidays this year.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these covid related issues.
© 2026 KFF